Anti-CD3 antibody and pharmaceutical composition for cancer treatment comprising same
US11498965B2 · kind B2 · utility
0Cited by
1References
16Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 22, 2018 |
| Grant date | Nov 15, 2022 |
| Priority date | — |
| Expiry date | May 22, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/56
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to an anti-CD3 antibody and a pharmaceutical composition for cancer treatment comprising same. The antibody according to the present invention has high affinity and specificity for CD3 and thus can be effectively used in cancer prevention or treatment.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.